United States · Series A startup

Who invested in Neuron Therapeutics

2 rounds we have observed, with the one investor named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

AI

Funding summaryUpdated 31 Oct 2026

$31Mraised across 2 rounds since 2014, from 2 sources

$7.6MVenture$24MSeries A
Latest round
Series A, $24MDec 2015
Step-upi
3.1×
Investors
1
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2015
$7.6MVenture$24MSeries A
First round
Venture, $7.6M
Dec 2014
Biggest round
$24M
Series A · Dec 2015
Between rounds
11 months
from the last two

The rounds

  1. Dec 2015
    Series A$24M1 new

    From a historical funding record

  2. Dec 2014
    Venture$7.6M

    No investor was named in the report.

    From a historical funding record

Everyone who backed them

The Column GroupVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Neuron Therapeutics

Who invested in Neuron Therapeutics?

Neuron Therapeutics's investors include The Column Group.

How much has Neuron Therapeutics raised?

Neuron Therapeutics has raised $31M across 2 rounds since 2014.

When did Neuron Therapeutics last raise?

Neuron Therapeutics's most recent round was a Series A of $24M in Dec 2015.

What was Neuron Therapeutics's biggest round?

Its most recent round, $24M in Dec 2015, is also its largest on record.

Who backed Neuron Therapeutics first?

Neuron Therapeutics's first round on record, in Dec 2015, was backed by The Column Group.

What stage is Neuron Therapeutics at?

Neuron Therapeutics's latest named round is a Series A, in Dec 2015.

Where is Neuron Therapeutics based?

Neuron Therapeutics is based in the United States.

Companies like Neuron Therapeutics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.